Ultraflex™ Tracheobronchial Stent System
Prosthesis, Tracheal, Expandable. 510(k) K230269, from Boston Scientific Corporation (Marlboro, MA). Product code JCT, class 2.
As of Nov 20, 2026, K230269 is an FDA 510(k) held by Boston Scientific Corporation, substantially equivalent on Jul 14, 2023 after 164 days, with no recalls tied to it in FDA's recall database.
- Review time: 164 days
- Recalls: 0
The Ultraflex™ Tracheobronchial Stent System is intended for use in the treatment of tracheobronchial strictures produced by malignant neoplasms.
- Ultraflex Tracheobronchial Covered Stent SystemK141584 · Boston Scientific Corporation · Oct 16, 2014
- Ultraflex Tracheobronchial Stent System- Sterile UncoveredK121048 · Boston Scientific Corp · Aug 3, 2012
- Through the Scope Tracheal Stent SystemK220424 · Micro-Tech (Nanjing) Co., Ltd. · Jul 8, 2022
- Tracheal Stent System (Y-Shaped)K212403 · Micro-Tech (Nanjing) Co., Ltd. · Oct 30, 2021
- Tracheal Stent SystemK202204 · Micro-Tech (Nanjing) Co., Ltd. · Sep 1, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Jan 31, 2023
- Review panel
- General, Plastic Surgery
- Regulation
- 21 CFR 878.3720
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files